Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
boston top stories
life sciences
national blog main
boston
national top stories
biotech
clinical trials
drugs
new york blog main
new york top stories
paul matteis
san francisco blog main
san francisco top stories
sickle cell disease
stifel
aldehyde
aldeyra therapeutics
allergic conjunctivitis
azacitidine
beta-thalassemia
biomarin
crispr
cystic fibrosis
cystic fibrosis foundation
dacogen
deals
decitabine
dna
dry eye disease
epigenetics
epizyme
farydak
fda
flagship pioneering
fulcrum therapeutics
gene therapy
gilead sciences
hemophilia
hepatitis c
What
step
4
×
data
medicines
new
therapeutics
aims
aldeyra
approach
based
biotech
called
cf
close
closer
crisis
cystic
debuts
developer
developing
disclosed
drug
drugs
epigenetic
epigenetics
eye
fda
fibrosis
field
fighting
filing
flagship’s
force
forward
gene
heated
helped
hemophilia
inflammation
jeff
leiden
Language
unknown
unset
Current search:
step
×
" boston blog main "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug